Debate Over TPP’s Intellectual Property Protection Provisions Expected Among U.S. Politicians

Washington Post: How the controversy over drug prices could take down Obama’s massive trade deal
“A political firestorm is building over the protections for drug companies in [the Trans Pacific Partnership (TPP)] international trade deal, threatening support for a key piece of the president’s legacy. The chapter addressing the issue, which was posted online Friday by WikiLeaks, grants at least five years of exclusivity to the makers of next-generation biologic medicines for diseases ranging from cancer to rheumatoid arthritis…” (Johnson, 10/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.